1. Ordu Üniversitesi Açık Arşiv Sistemi
  2. FAKÜLTELER
  3. Tıp Fakültesi
  4. Dahili Tıp Bilimleri
Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2460
Full metadata record
DC FieldValueLanguage
dc.contributor.authorErdogan, Guney-
dc.contributor.authorGunaydin, Zeki Yuksel-
dc.contributor.authorGurel, Yusuf Emre-
dc.contributor.authorKaya, Ahmet-
dc.date.accessioned2022-08-17T05:58:08Z-
dc.date.available2022-08-17T05:58:08Z-
dc.date.issued2014-
dc.identifier.urihttp://doi.org/10.5152/akd.2014.5668-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2460-
dc.description.abstractAxitinib is a novel tyrosine kinase inhibitor which is a second-line option for the treatment of metastatic renal cell carcinoma with progression after previous therapy (1, 2). We present the first reported case of acute myocardial infarction in a patient receiving axitinib.en_US
dc.language.isoengen_US
dc.publisherTURKISH SOC CARDIOLOGYCOBANCESME SANAYI CAD NO 11, NISH ISTANBUL A BLOK KAT 8 NO 47-48, YENIBOSNA, BAHCELIEVLER, ISTANBUL 34196, TURKEYen_US
dc.relation.isversionof10.5152/akd.2014.5668en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdjuvant systemic therapy was initiated to treat residual metastatic diseaseen_US
dc.titlePeripartum cardiomyopathy associated with triplet pregnancyen_US
dc.typearticleen_US
dc.relation.journalANATOLIAN JOURNAL OF CARDIOLOGYen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0001-5205-1326en_US
dc.contributor.authorID0000-0001-9779-7578en_US
dc.identifier.volume14en_US
dc.identifier.issue7en_US
dc.identifier.startpage661en_US
dc.identifier.endpage662en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.